Lichen China Ltd. Enters Securities Purchase Agreement
Ticker: LICN · Form: 6-K · Filed: Dec 17, 2024 · CIK: 1876766
| Field | Detail |
|---|---|
| Company | Lichen China LTD (LICN) |
| Form Type | 6-K |
| Filed Date | Dec 17, 2024 |
| Risk Level | medium |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $0.00004, $0.18, $0.179, $2.7 million, $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financing, agreement
TL;DR
Lichen China Ltd. signed a deal with institutional investors on Dec 12, 2024. Details TBD.
AI Summary
On December 12, 2024, Lichen China Limited entered into a securities purchase agreement with certain institutional investors. The filing does not specify the dollar amounts involved in this agreement.
Why It Matters
This agreement signifies potential new investment or financing for Lichen China Limited, which could impact its future operations and growth.
Risk Assessment
Risk Level: medium — The filing indicates a significant corporate action (securities purchase agreement) but lacks specific financial details, creating uncertainty.
Key Players & Entities
- Lichen China Limited (company) — Registrant
- December 12, 2024 (date) — Date of securities purchase agreement
- institutional investors (company) — Purchasers in the agreement
FAQ
What is the total value of the securities purchased under the agreement?
The filing does not disclose the total dollar amount of the securities purchase agreement.
Who are the specific institutional investors that entered into the agreement?
The filing refers to 'certain institutional investors named thereto' but does not list their names.
What type of securities were purchased in the agreement?
The filing mentions a 'securities purchase agreement' but does not specify the type of securities involved.
What is the purpose of this securities purchase agreement for Lichen China Limited?
The filing does not state the specific purpose or intended use of funds from the securities purchase agreement.
When is the closing date for this securities purchase agreement?
The filing does not provide information regarding the closing date of the agreement.
Filing Stats: 1,411 words · 6 min read · ~5 pages · Grade level 14.5 · Accepted 2024-12-17 16:30:03
Key Financial Figures
- $0.00004 — hares”) of the Company, par value $0.00004 per share (the “Shares”), a
- $0.18 — ;Shares”), at a purchase price of $0.18 per share; and (ii) pre-funded warrants
- $0.179 — Warrants”) at a purchase price of $0.179 per Pre-Funded Warrant. The Registered
- $2.7 million — 024. The Company received approximately $2.7 million in gross proceeds from the Registered D
- $0.001 — Ordinary Share at an exercise price of $0.001 per share. The Pre-Funded Warrants are
- $50,000 — ect Offering in an amount not to exceed $50,000. 1 The foregoing summaries of the Pla
- $2.70 Million — d “Lichen China Limited Announces $2.70 Million Registered Direct Offering” is fu
Filing Documents
- ea0224827-6k_lichen.htm (6-K) — 24KB
- ea022482701ex4-1_lichen.htm (EX-4.1) — 92KB
- ea022482701ex5-1_lichen.htm (EX-5.1) — 55KB
- ea022482701ex5-2_lichen.htm (EX-5.2) — 17KB
- ea022482701ex10-1_lichen.htm (EX-10.1) — 88KB
- ea022482701ex10-2_lichen.htm (EX-10.2) — 204KB
- ea022482701ex99-1_lichen.htm (EX-99.1) — 8KB
- ex5-1_001.jpg (GRAPHIC) — 6KB
- ex5-2_001.jpg (GRAPHIC) — 22KB
- 0001213900-24-109789.txt ( ) — 527KB
Forward-Looking Statements
Forward-Looking Statements : This Report contains forward-looking other Federal securities laws. For example, the Company is using forward-looking statements when it discusses the closing of the Registered Direct Offering. All statements other than statements of historical facts included in this Report are forward-looking statements. Forward-looking beliefs, expectations and assumptions regarding the future of its business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company’s control. The Company’s actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include the risks and uncertainties described in the Company’s annual report on Form 20-F for the year ended December 31, 2023, filed with the Commission on April 4, 2024, and the Company’s other filings with the Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise. 2 Exhibit Index Exhibit No. Description 4.1 Form of Pre-Funded Warrant 5.1 Opinion of Appleby 5.2 Opinion of Ortol
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Lichen China Limited By: /s/ Ya Li Name: Ya Li Title: Chief Executive Officer Date: December 17, 2024 4